大型骨科手术中术前贫血治疗的临床与预算影响——一项回顾性观察研究
该回顾性研究纳入2016至2018年所有择期髋/膝关节置换术共881例,术前贫血患病率为21.5%。预算影响模型显示,基于筛查并治疗缺铁性贫血患者可获得与非贫血患者相同结局的假设,每例患者可节省254欧元。
要点
- 择期髋/膝关节置换术患者术前贫血患病率为21.5%。
- 术前贫血独立预测输血风险增加(ORadj 9.5)和住院时间延长(ORadj 2.8)。
- 预算影响模型显示筛查并治疗术前贫血每例患者可节省254欧元。
核心结论
- 筛查和治疗术前贫血可减少输血和住院时间从而降低成本,并可能减少择期大型骨科手术的并发症。
研究设计与样本
- 回顾性观察研究,纳入2016至2018年期间所有择期髋/膝关节置换术,共881例手术。
- 比较血红蛋白正常患者与术前贫血患者(男性血红蛋白<13.0 g/dL,女性<12.0 g/dL)。
- 基于术前贫血相关成本结果,建立筛查术前贫血及必要时静脉铁剂治疗的预算影响模型。
主要发现
- 术前贫血患病率为21.5%。
- 术前贫血导致每例患者成本增加(P < .001)。
- 预算影响模型显示,基于筛查并治疗缺铁性贫血患者可获得与非贫血患者相同结局的假设,每例患者成本降低254欧元。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preoperative anemia (POA) in elective surgery is associated with worse outcome. In this retrospective study, in elective hip and knee arthroplasties, the prevalence of POA and its associations with outcome were analyzed, followed by a model estimating the budget impact of screening and treatment of POA. METHODS: All elective hip/knee arthroplasties performed during the period 2016-2018 were included. Patients with normal hemoglobin and patients with POA (hemoglobin < 13.0 g/dL in men and <12.0 g/dL in women) were compared. Outcome measures were allogeneic blood transfusion (ABT), length of stay (LOS), complications, mortality, and costs. The budget impact of screening for POA and treatment with intravenous iron when relevant was modeled based on the results of the costs related to POA. RESULTS: In 881 procedures, the prevalence of POA was 21.5%. POA independently predicted increased risks of ABT (odds ratio [OR]adj, 9.5 [confidence interval-CI, 6.4-13.9]), prolonged LOS (ORadj, 2.8 [CI, 1.8-4.2]), and was associated with increased complications (ORadj, 1.9 [CI, 0.7-4.9]) and mortality (ORadj, 3.2 [CI, 0.8-13.5]). POA resulted in increased costs per patient (P < .001). The budget impact model showed a cost reduction of 254 euros per patient based on the assumption that patients screened and treated for iron-deficient anemia would have the same outcome as non-POA. CONCLUSION: The prevalence of POA in elective orthopedic surgery in Sweden is at the same level as previously reported by others. Screening and treatment of POA would reduce costs based on less ABT and decreased LOS and may reduce complications in elective major orthopedic surgery.
引用
- Wan S, Sparring V, Cabrales DA, et al. Clinical and Budget Impact of Treating Preoperative Anemia in Major Orthopedic Surgery-A Retrospective Observational Study. J Arthroplasty. 2020. PMID: 32654943. doi:10.1016/j.arth.2020.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。